| |
|
|
| Name: |
DAFNA CAPITAL MANAGEMENT LLC |
| City: |
LOS ANGELES |
| State: |
CA |
| Zip: |
90024 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
6 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
SBTX |
Silverback Therapeutics, Inc. |
46 |
New |
$0.00 |
$1,705,000 |
311,169 |
0.41% |
1,705,000 |
311,169 |
0.18 |
N/A |
|
|
ARGX |
Argenx Se |
53 |
New |
$388.20 |
$1,370,000 |
3,600 |
0.33% |
1,370,000 |
3,600 |
0.008 |
N/A |
|
|
IMTX |
Immatics N.V |
58 |
New |
$10.77 |
$1,106,000 |
105,000 |
0.27% |
1,106,000 |
105,000 |
0.167 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
61 |
New |
$0.00 |
$670,000 |
72,797 |
0.16% |
670,000 |
72,797 |
0.185 |
N/A |
|
|
VTGN |
Vistagen Therapeutics Inc |
69 |
New |
$4.50 |
$215,000 |
41,886 |
0.05% |
215,000 |
41,886 |
0.434 |
Biotechnology |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
73 |
New |
$0.00 |
$131,000 |
15,200 |
0.03% |
131,000 |
15,200 |
0.037 |
N/A |
|
